{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:20:40Z","timestamp":1785352840651,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bmc.2020.115424","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:11:40Z","timestamp":1584429100000},"page":"115424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Design, synthesis &amp; biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX"],"prefix":"10.1016","volume":"28","author":[{"given":"Babita","family":"Aneja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarfa","family":"Queen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farheen","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phool","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Moshahid A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin G.","family":"Daniliuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115424_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrd3144","article-title":"Anticancer drug development: the grand challenges","volume":"9","author":"Hait","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2020.115424_b0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The Metabolism of Tumors in the Body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.bmc.2020.115424_b0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","article-title":"Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression","volume":"18","author":"Fang","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2020.115424_b0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2020.115424_b0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2020.115424_b0030","first-page":"404","article-title":"Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target","volume":"2010","author":"De Simone","year":"1804","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2020.115424_b0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2020.115424_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metast Rev"},{"key":"10.1016\/j.bmc.2020.115424_b0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115424_b0050","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Supuran, discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115424_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acsmedchemlett.8b00100","article-title":"Sweet binders: carbonic anhydrase IX in complex with sucralose","volume":"9","author":"Lomelino","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115424_b0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/acsmedchemlett.9b00023","article-title":"alpha, gamma-diketocarboxylic acids and their esters act as carbonic anhydrase IX and XII selective inhibitors","volume":"10","author":"Nocentini","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115424_b0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1747-0285.2010.00965.x","article-title":"Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids","volume":"75","author":"Sarikaya","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2020.115424_b0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejmech.2018.12.026","article-title":"Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis","volume":"163","author":"Aneja","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijbiomac.2017.08.082","article-title":"Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors","volume":"106","author":"Queen","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2020.115424_b0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2174\/1389203718666170810145436","article-title":"Understanding the role and mechanism of carbonic anhydrase V in obesity and its therapeutic implications","volume":"19","author":"Queen","year":"2018","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.bmc.2020.115424_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21121649","article-title":"Phenols and polyphenols as carbonic anhydrase inhibitors","volume":"21","author":"Karioti","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2020.115424_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2020.115424_b0095","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.bmc.2010.01.076","article-title":"Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/2211352514666160606115200","article-title":"Biological activities and in silico physico-chemical properties of 1,2,3- triazoles derived from natural bioactive alcohols","volume":"14","author":"Irfan","year":"2016","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.bmc.2020.115424_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmc.2020.115424_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.05.034","article-title":"Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents","volume":"155","author":"Peerzada","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijbiomac.2016.06.080","article-title":"GdnHCl-induced unfolding intermediate in the mitochondrial carbonic anhydrase VA","volume":"91","author":"Idrees","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2020.115424_b0125","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2020.115424_b0130","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1021\/ct1003077","article-title":"How can hydrophobic association be enthalpy driven?","volume":"6","author":"Setny","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2020.115424_b0135","doi-asserted-by":"crossref","first-page":"17889","DOI":"10.1073\/pnas.1114107108","article-title":"Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2020.115424_b0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmc.2020.115424_b0145","doi-asserted-by":"crossref","unstructured":"Pastorekova S, Gillies RJ. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metast Rev, vol. 38, p. 65\u201377.","DOI":"10.1007\/s10555-019-09799-0"},{"key":"10.1016\/j.bmc.2020.115424_b0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bioorg.2018.11.014","article-title":"SLC-0111 enaminone analogs, 3\/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX","volume":"83","author":"Eldehna","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0155","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0160","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1021\/ol900562u","article-title":"Accessing skeletal diversity using catalyst control: formation of n and n + 1 macrocyclic triazole rings","volume":"11","author":"Kelly","year":"2009","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2020.115424_b0165","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1021\/jm4003928","article-title":"1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor alpha","volume":"56","author":"Xu","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0170","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1039\/b703420b","article-title":"Synthesis of bitriazolyl nucleosides and unexpectedly different reactivity of azidotriazole nucleoside isomers in the Huisgen reaction","volume":"5","author":"Xia","year":"2007","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0175","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0180","unstructured":"Systemes D. BIOVIA, Discovery Studio Modeling Environment. Release 4.5. San Diego (CA): Dassault Systemes; 2015."},{"key":"10.1016\/j.bmc.2020.115424_b0185","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ijbiomac.2016.10.073","article-title":"Ahmad, Characterization of folding intermediates during urea-induced denaturation of human carbonic anhydrase II","volume":"95","author":"Wahiduzzaman","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2020.115424_b0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12010-014-0850-1","article-title":"Luminol-based chemiluminescent signals: clinical and non-clinical application and future uses","volume":"173","author":"Khan","year":"2014","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.bmc.2020.115424_b0195","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1021\/acs.molpharmaceut.8b00566","article-title":"Thienopyrimidine-chalcone hybrid molecules inhibit Fas-activated serine\/threonine kinase: an approach to ameliorate antiproliferation in human breast cancer cells","volume":"15","author":"Khan","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2020.115424_b0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2018.09.030","article-title":"Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors","volume":"159","author":"Parveen","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115424_b0205","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1021\/ja01164a032","article-title":"The quenching of fluorescence. Deviations from the Stern-Volmer law","volume":"72","author":"Boaz","year":"1950","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2020.115424_b0210","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1038\/s41598-017-09941-4","article-title":"Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2020.115424_b0215","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/acs.jnatprod.9b00372","article-title":"Identification of alpha-mangostin as a potential inhibitor of microtubule affinity regulating kinase 4","volume":"82","author":"Khan","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2020.115424_b0220","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41598-018-38217-8","article-title":"Probing the inhibition of microtubule affinity regulating kinase 4 by N-substituted acridones","volume":"9","author":"Voura","year":"2019","journal-title":"Sci Rep"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620302340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620302340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:07:09Z","timestamp":1760836029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620302340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0968089620302340"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115424","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115424"}}